Our data was in line with the other studies indicating that increased LRG1 expression was presented in ovarian cancer [11], non-small cell lung cancer [12], gastric cancer [13], pancreatic cancer [14] and leukemia [15]. This evidence concerns the gene LRG1 and ovarian carcinoma.